THE LATEST NEWS IN CANCER CLINICAL RESEARCH

New EU Clinical Trials Regulation

It was great to be back at ASCO!

Spotlight: Abigail breast cancer trial

We are part of I3LUNG, a project funded by the European Union!

We enjoyed presenting our work at ESMO BREAST 2022

We’re presenting at ESMO Breast Cancer 2022!

PHERGain-2: Approved in 5 countries

The Important Step of Identifying an Unmet Need for Your IIT

Spotlight: LUZERN Breast Cancer Trial

MEDSIR signs a strategic alliance with Oncoclínicas to strengthen its international expansion

Spotlight – PECATI trial on rare thymic tumors

MEDSIR’s Experience at ASCO GU 2022: Update on our 2 GU trials

World Cancer Day – Closing the Care Gap

Spotlight – DEBBRAH breast cancer trial

Cancer Vaccine could be key to modulating tumor microenvironment for metastatic pancreatic cancer

Spotlight: PHERGain-2 HER2+ early breast cancer trial

It’s that time of year again! It’s MOVEMBER!

Toripalimab joins the list of ICIs that improve efficacy when added to chemotherapy in 1L NSCLC

Dr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer

DESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer